hydroxychloroquine has been researched along with Protein-Losing Enteropathies in 2 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Protein-Losing Enteropathies: Pathological conditions in the INTESTINES that are characterized by the gastrointestinal loss of serum proteins, including SERUM ALBUMIN; IMMUNOGLOBULINS; and at times LYMPHOCYTES. Severe condition can result in HYPOGAMMAGLOBULINEMIA or LYMPHOPENIA. Protein-losing enteropathies are associated with a number of diseases including INTESTINAL LYMPHANGIECTASIS; WHIPPLE'S DISEASE; and NEOPLASMS of the SMALL INTESTINE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horino, T | 1 |
| Ogasawara, M | 1 |
| Kashio, T | 1 |
| Inotani, S | 1 |
| Ishihara, M | 1 |
| Ohnishi, H | 1 |
| Komori, M | 1 |
| Ichii, O | 1 |
| Terada, Y | 1 |
| Liao, CY | 1 |
| Chien, ST | 1 |
| Wang, CC | 1 |
| Chen, IH | 1 |
| Chiu, HW | 1 |
| Liu, MY | 1 |
| Lin, CH | 1 |
| Ben, RJ | 1 |
| Tsai, MK | 1 |
2 other studies available for hydroxychloroquine and Protein-Losing Enteropathies
| Article | Year |
|---|---|
Lupus-related protein-losing enteropathy associated with pseudo-pseudo Meigs' syndrome and successfully treated with hydroxychloroquine.
Topics: Ascites; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Meigs Syndrome; Protein- | 2022 |
Sjögren's syndrome associated with protein losing gastroenteropathy manifested by intestinal lymphangiectasia successfully treated with prednisolone and hydroxychloroquine.
Topics: Adult; Anti-Inflammatory Agents; Antirheumatic Agents; Female; Humans; Hydroxychloroquine; Lymphangi | 2015 |